跳至主要内容
临床试验/NCT04711213
NCT04711213已完成2 期

A Phase 2 Clinical Study to Assess the Efficacy and Safety of SED80 for the Treatment of Inflammation and Pain Associated With Cataract Surgery

iDrop, Inc.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年9月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
iDrop, Inc.
入组人数
60
试验地点
1
主要终点
Ocular inflammation

研究概览

简要总结

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to determine if the drops decrease inflammation and pain inside the eye and are safe after cataract surgery.

详细描述

"Patients undergoing traditional cataract surgery routinely develop inflammation and pain. This study will evaluate 4 arms of either dexamethasone or placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Single Masked randomized study

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing traditional cataract surgery.

排除标准

  • Patients with unusual ocular conditions.

研究组 & 干预措施

Placebo Dose 2

Placebo Comparator

干预措施: Placebo Dose 2 (Drug)

Dexamethasone Dose 1

Active Comparator

干预措施: Dexamethasone Dose 1 (Drug)

Dexamethasone Dose 2

Active Comparator

干预措施: Dexamethasone Dose 2 (Drug)

Placebo Dose 1

Placebo Comparator

干预措施: Placebo Dose 1 (Drug)

结局指标

主要结局

Ocular inflammation

时间窗: Day 8

Measuring Anterior Cell Count

次要结局

  • Ocular Pain(Day 8)

研究者

发起方
iDrop, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Clinical Study to Assess the Efficacy and Safety... | 临床试验